PETMED EXPRESS INC (PETS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PETS currently has 20.9M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 3.39% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Jun 02, 2026 |
10-K filing | 20.9M shares outstanding |
21M | 0 |
| Dec 19, 2025 |
10-Q filing | 20.8M shares outstanding |
21M | 0 |
| Dec 19, 2025 |
10-Q filing | 20.9M shares outstanding |
21M | 0 |
| Oct 14, 2025 |
10-K filing | 20.6M shares outstanding |
21M | 0 |
| Feb 10, 2025 |
10-Q filing | 20.6M shares outstanding |
21M | 0 |
| Dec 03, 2024 |
8-K filing: The Board adopted Articles of Amendment to the Amended and Restated Articles of Incorporation, designating the rights, preferences, and privileges of 100,000 shares of a new series of the Company's preferred stock, par value $0.001 per share, designated as Series A Junior Participating Preferred Stock. |
21M | 0 |
| Nov 07, 2024 |
10-Q filing | 20.6M shares outstanding |
21M | 0 |
| Aug 07, 2024 |
10-Q filing | 20.5M shares outstanding |
21M | 0 |
| Jun 14, 2024 |
10-K filing | 20.4M shares outstanding |
20M | 0 |
| Apr 15, 2024 |
10-Q filing | 20.4M shares outstanding |
20M | 0 |
| Oct 31, 2023 |
10-Q filing | 20.4M shares outstanding |
20M | 0 |
| Aug 02, 2023 |
10-Q filing | 20.3M shares outstanding |
20M | 0 |
| May 23, 2023 |
10-K filing | 20.3M shares outstanding |
20M | 0 |
| Feb 07, 2023 |
10-Q filing | 20.3M shares outstanding |
20M | 0 |
| Nov 08, 2022 |
10-Q filing | 20.3M shares outstanding |
20M | 0 |
| Aug 02, 2022 |
10-Q filing | 20.3M shares outstanding |
20M | 0 |
| May 24, 2022 |
10-K filing | 20.4M shares outstanding |
20M | 0 |
| Feb 04, 2022 |
10-Q filing | 20.3M shares outstanding |
20M | 0 |
| Nov 02, 2021 |
10-Q filing | 20.6M shares outstanding |
21M | 0 |
| Jul 30, 2021 |
10-Q filing | 20.2M shares outstanding |
20M | 0 |
| Jun 15, 2021 |
8-K filing: PetMed Express, Inc. entered into a CEO Separation Agreement with Menderes Akdag, the Company's President and Chief Executive Officer, which provides for the vesting of 37,800 restricted shares held by Mr. Akdag on July 31, 2021. |
20M | 0 |
| May 25, 2021 |
10-K filing | 20.1M shares outstanding |
20M | 0 |
| Jan 26, 2021 |
10-Q filing | 20.1M shares outstanding |
20M | 0 |
| Nov 03, 2020 |
10-Q filing | 20.2M shares outstanding |
20M | 0 |
| Aug 03, 2020 |
10-Q filing | 20.0M shares outstanding |
20M | 0 |
| May 26, 2020 |
10-K filing | 20.1M shares outstanding |
20M | 0 |
| Jan 28, 2020 |
10-Q filing | 20.0M shares outstanding |
20M | 0 |